Overview
- Apollo Hospitals’ Q1 FY26 consolidated net profit rose 42% year-on-year to ₹433 crore, outpacing the Bloomberg consensus by over ₹55 crore on revenue growth of nearly 15% to ₹5,842 crore and a 14.6% EBITDA margin.
- The hospital chain plans to operationalize six new facilities with more than 1,500 beds this year under a five-year programme to add over 4,300 beds.
- Management is reallocating medical-tourism efforts away from Bangladesh to target patient inflows from Africa-Middle East, Southeast Asia and CIS markets following a 1.5% revenue hit from Bangladeshi patient declines.
- A board-approved composite scheme will spin off the omnichannel pharmacy and digital-health operations into Apollo Healthtech, with a 12–18-month timeline set for its public listing.
- Apollo 24/7’s digital pharmacy business is projected to break even by Q4 FY26 as it scales post-demerger toward a potential ₹25,000 crore run-rate by FY27.